Published in Obesity and Diabetes Week, October 13th, 2003
The grant was awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) at the National Institutes of Health (NIH).
The phase I $100,000 award has already been released to support the initial clinical safety component of the study. The $750,000 phase II award will support a randomized, placebo controlled, efficacy trial. The phase II funds will be released via a Streamlined...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week